본문으로 바로가기 주메뉴 바로가기

사용자별 맞춤메뉴

자주찾는 메뉴

추가하기
닫기

연구성과

contents area

detail content area

FAST: Size-selective, clog-free isolation of rare cancer cells from whole blood at a liquid-liquid interface
  • 작성일2018-02-14
  • 최종수정일2018-02-14
  • 담당부서연구기획과
  • 연락처043-719-8033
  • 2,271
Analytical chemistry, 2017, 01, 1155─1162, DOI: https://doi.org/10.1021/acs.analchem.6b03534

FAST: Size-selective, clog-free isolation of rare cancer cells from whole blood at a liquid-liquid interface

Tae-Hyeong Kim, Minji Lim; Juhee Park; Jung Min Oh; Hyeongeun Kim; Hyunjin Jeong; Sun Ju Lee; Hee Chul Park; Sungmok Jung; Byung Chul Kim; Kyusang Lee; Mi-Hyun Kim; Do Youn Park; Gwang Ha Kim; Yoon-Kyoung Cho

Abstract

    Circulating tumor cells (CTCs) have great potential to provide minimally invasive ways for the early detection of cancer metastasis and for the response monitoring of various cancer treatments. Despite the clinical importance and progress of CTC-based cancer diagnostics, most of the current methods of enriching CTCs are difficult to implement in general hospital settings due to complex and timeconsuming protocols. Among existing technologies, sizebased isolation methods provide antibody-independent, relatively simple, and high throughput protocols. However, the clogging issues and lower than desired recovery rates and purity are the key challenges. In this work, inspired by antifouling membranes with liquid-filled pores in nature, clogfree, highly sensitive (95.9 ± 3.1% recovery rate), selective (>2.5 log depletion of white blood cells), rapid (>3 mL/min), and label-free isolation of viable CTCs from whole blood without prior sample treatment is achieved using a stand-alone lab-on-a-disc system equipped with fluid-assisted separation technology (FAST). Numerical simulation and experiments show that this method provides uniform, clog-free, ultrafast cell enrichment with pressure drops much less than in conventional size-based filtration, at 1 kPa.
    We demonstrate the clinical utility of the point-of-care detection of CTCs with samples taken from 142 patients suffering from breast, stomach, or lung cancer.



  • 본 연구는 질병관리본부 연구개발과제(과제번호 2017-보건의료생물자원종합관리) 연구비를 지원받아 수행되었습니다.
  • This research was supported by a fund(code 2017-보건의료생물자원종합관리) by Research of Korea Centers for Disease Control and Prevention.


본 공공저작물은 공공누리  출처표시+상업적이용금지+변경금지 조건에 따라 이용할 수 있습니다 본 공공저작물은 공공누리 "출처표시+상업적이용금지+변경금지" 조건에 따라 이용할 수 있습니다.
TOP